BRNS - CIK 0001828185
Barinthus Biotherapeutics plc. (BRNS) reported revenue of $0.00 for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $0.00 | -100.0% |
| FY 2024 | $14.97M | +1766.5% |
| FY 2023 | $802.00K | -98.2% |
| FY 2022 | $44.70M | +16580.2% |
| FY 2021 | $268.00K | -94.4% |
| FY 2020 | $4.82M | - |
Barinthus Biotherapeutics plc. (BRNS) reported revenue of $0.00 for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2020 and fiscal 2025, Barinthus Biotherapeutics plc.'s revenue declined from $4.82M to $0.00.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.